India is expanding its research efforts to tackle diabetes, with more than a dozen projects exploring new ways to prevent and manage the disease. The research includes studies on gut bacteria, genetic mechanisms, insulin signalling and next-generation therapies that could help improve diabetes treatment in the future.
The developments were highlighted at the Research Society for the Study of Diabetes in India (RSSDI) 2026 conference in Bengaluru .
Scientists Explore New Approaches to Diabetes Treatment
Several ongoing projects are investigating how molecular and genetic mechanisms influence diabetes. One Indo-Danish study is examining differences in gut microbiota among Indian people with prediabetes and diabetes.
Researchers are also exploring engineered gut bacteria that could produce GLP-1, a hormone involved in blood sugar regulation. This is an experimental research approach, and human studies are expected to be undertaken.
Research Focuses on Insulin and Blood Sugar Regulation
Other projects are examining insulin signalling, genetic mechanisms and potential ways to improve glucose regulation.
Researchers are also investigating temperature-resilient insulin, which could make storage and transportation easier, particularly in areas where maintaining cold storage is difficult.
Work on oral insulin is another area being explored, although these approaches are still under development.
Indigenous Diabetes Treatments Receive Attention
India is also strengthening its capabilities in developing affordable diabetes treatments. Progress in biosimilar medicines, including liraglutide and insulin lispro, is part of these efforts.
The research aims to support wider access to treatment while encouraging innovation within India’s healthcare and biotechnology sectors.
Experts Highlight Rising Diabetes Risk Among Young People
The growing burden of obesity and diabetes among younger people has become an important public health concern.
Researchers emphasise that prevention, balanced nutrition, regular physical activity and timely medical attention remain essential alongside scientific advances.
The ongoing projects could open new possibilities for diabetes care, but experimental treatments will need proper clinical evaluation before they can become routine medical options.
